You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Kinase Inhibitors

Showing 1 - 25 of 6,498
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023

Cancer Trial in Changsha (Protein Kinase Inhibitor)

Recruiting
  • Cancer
  • Protein Kinase Inhibitor
  • Changsha, Hunan, China
    Central South University
Jun 23, 2022

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)

Recruiting
  • Non Small Cell Lung Cancer
  • Metformin Hydrochloride
  • Placebo
  • Mexico City, Mexico
    Instituto Nacional de Cancerologia
Jul 21, 2022

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes

Active, not recruiting
  • Patients Diagnosed as Chronic Meyloid Leukemia
  • Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
  • Assiut, Egypt
    Assiut University Hospital
Feb 19, 2022

Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

Recruiting
  • Olverembatinib
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Jul 26, 2022

Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Rotterdam, Netherlands
      Erasmus MC
    Feb 2, 2022

    Kidney Tumor Trial in France (blood sampling for ITK dosage)

    Recruiting
    • Kidney Neoplasm
    • blood sampling for ITK dosage
    • Marseille, France
    • +4 more
    Jan 6, 2023

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

    Not yet recruiting
    • Leukemia
    • +4 more
    • (no location specified)
    Jul 27, 2022

    CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

    Recruiting
    • CML
    • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
    • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
      FUNDALEU
    Jun 29, 2023

    Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

    Recruiting
    • Atrial Fibrillation
    • +4 more
    • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
    • New Hyde Park, New York
      Northwell (Northshore University/Long Island Jewish Hospitals)
    Dec 1, 2022

    Tyrosine Kinase Inhibitors in Trastuzumab Emtansine Resistant

    Recruiting
    • Breast Cancer
    • Nanjing, Jiangsu, China
      Jiangsu Provincial People's Hospital
    Feb 7, 2022

    Melanoma (Skin) Trial in Dijon, Thionville, Vandœuvre-lès-Nancy (Blood sampling)

    Active, not recruiting
    • Melanoma (Skin)
    • Blood sampling
    • Dijon, France
    • +3 more
    Mar 29, 2022

    Carcinoma, Adenoid Cystic Trial in Qingdao (EGFR-TK Inhibitor)

    Recruiting
    • Carcinoma, Adenoid Cystic
    • EGFR-TK Inhibitor
    • Qingdao, Shandong, China
      Qingdao central Hospital
    Nov 1, 2021

    Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

    Not yet recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Amivantamab 1050mg
    • +2 more
    • Aurora, Colorado
    • +2 more
    Apr 25, 2023

    NSCLC With EGFR Mutation Trial in Mexico City (Glutamine plus L. reuteri)

    Recruiting
    • Non-Small Cell Lung Cancer With EGFR Mutation
    • Glutamine plus L. reuteri
    • Mexico City, Mexico
      Instituto Nacional de Cancerologia de Mexico
    May 2, 2023

    Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

    Recruiting
    • Breast Cancer Stage IV
    • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
    • Mansoura, Dakahlia, Egypt
      Oncology center mansoura university
    Jan 1, 2023

    Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

    Completed
    • Leukemia
    • No Intervention
    • Cambridge, Massachusetts
      Takeda
    Feb 28, 2023

    NSCLC Stage IIIB~IV Trial in Taipei (Atezolizumab Injection; bevacizumab Injection)

    Recruiting
    • NSCLC Stage IIIB~IV
    • Atezolizumab Injection; bevacizumab Injection
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jan 18, 2022

    METAstatic Gastrointestinal Stromal Tumors (METAGIST)

    Recruiting
    • Gastro Intestinal Stromal Tumor
    • oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations
    • Bordeaux, France
      Institut Bergonié, Comprehensive Cancer Center
    Dec 1, 2022

    TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

    Recruiting
    • Chronic Myeloid Leukemia
    • Pisa, Italy
    • +1 more
    Jan 4, 2022

    Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)

    Recruiting
    • Protein Kinase Inhibitors
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Nov 9, 2023